Coffee consumption and risk of endometrial cancer: A dose-response meta-analysis of prospective cohort studies

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhou, Quan ^a   Luo, Mei Ling ^a   Li, Hui ^a   Li, Min ^b   Zhou, Jian Guo ^c  

^a Department of Science and Education First People's Hospital of Changde City ^*  (China)

^b NANCHANG UNIVERSITY   (China)

^c ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; COFFEE;

ADULT; AGE DISTRIBUTION; AGED; CAUSALITY; COFFEE; COHORT ANALYSIS; DRINKING BEHAVIOR; ENDOMETRIAL NEOPLASMS; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; META ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

ADULT; AGE DISTRIBUTION; AGED; CAFFEINE; CAUSALITY; COFFEE; COHORT STUDIES; DRINKING BEHAVIOR; ENDOMETRIAL NEOPLASMS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84940034283     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13410     Document Type: Article

References (59)

1. Jemal, A. et al. Global cancer statistics. CA-Cancer J Clin 61, 69-90, doi: 10.3322/caac.20107 (2011).
2. Olesen, T. B. et al. Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 134, 206-215, doi: 10.1016/j.ygyno.2014.02.040 (2014).
3. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA-Cancer J Clin 65, 5-29, doi: 10.3322/caac.21254 (2015).
4. Weisse, A. B. Coffee: grounds for concern? Proceedings (Baylor University. Medical Center) 28, 122-123 (2015).
5. Bohn, S. K., Blomhoff, R. & Paur, I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 58, 915-930, doi: 10.1002/mnfr.201300526 (2014).
6. Je, Y. & Giovannucci, E. Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. Br J Nutr 111, 1162-1173, doi: 10.1017/s0007114513003814 (2014).
7. Crippa, A., Discacciati, A., Larsson, S. C., Wolk, A. & Orsini, N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol 180, 763-775, doi: 10.1093/aje/kwu194 (2014).
8. Malerba, S. et al. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol 28, 527-539, doi: 10.1007/s10654-013-9834-7 (2013).
9. Research, W. C. R. F. A. I. f. C. Continuous Update Project Report: Endometrial Cancer 2013 Report. (2013).
10. Yu, X., Bao, Z., Zou, J. & Dong, J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11, 96, doi: 10.1186/1471-2407-11-96 (2011).
11. Wu, W. et al. Tea and coffee and risk of endometrial cancer: cohort study and meta-analysis. Am J Clin Nutr 101, 570-578, doi: 10.3945/ajcn.113.081836 (2015).
12. Je, Y. & Giovannucci, E. Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis. Int J cancer. 131, 1700-1710, doi: 10.1002/ijc.27408 (2012).
13. Bravi, F. et al. Coffee drinking and endometrial cancer risk: a meta-analysis of observational studies. Am J Obstet Gynecol 200, 130-135, doi: 10.1016/j.ajog.2008.10.032 (2009).
14. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283, 2008-2012 (2000).
15. Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol 25, 603-605, doi: 10.1007/s10654-010-9491-z (2010).
16. Fang, X. et al. Dietary intake of heme iron and risk of cardiovascular disease: A dose-response meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis, doi: 10.1016/j.numecd.2014.09.002 (2014).
17. Zhou, J. G. et al. Treatment on advanced NSCLC: platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials. Med Oncol 32, 471, doi: 10.1007/s12032-014-0471-0 (2015).
18. Atkins, D. et al. Grading quality of evidence and strength of recommendations. BMJ 328, 1490, doi: 10.1136/bmj.328.7454.1490 (2004).
19. Ma, J. et al. Intramedullary nail versus dynamic compression plate fixation in treating humeral shaft fractures: grading the evidence through a meta-analysis. PloS One 8, e82075, doi: 10.1371/journal.pone.0082075 (2013).
20. Greenland, S. Quantitative methods in the review of epidemiologic literature. Epidemiol rev 9, 1-30 (1987).
21. Wu, W. et al. Coffee consumption and bladder cancer: a meta-analysis of observational studies. Sci Rep 5, 9051, doi: 10.1038/srep09051 (2015).
22. Greenland, S. & Longnecker, M. P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135, 1301-1309 (1992).
23. Orsini, N., Bellocco, R. & Greenland, S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 6, 40 (2006).
24. Orsini, N., Li, R., Wolk, A., Khudyakov, P. & Spiegelman, D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175, 66-73, doi: 10.1093/aje/kwr265 (2012).
25. Higgins, J. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539-1558 (2002).
26. Der Simonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177-188 (1986).
27. Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101 (1994).
28. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997).
29. Duval, S. & Tweedie, R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 56, 455-463 (2000).
30. Cafri, G., Kromrey, J. D. & Brannick, M. T. A SAS macro for statistical power calculations in meta-analysis. Behav Res Methods 41, 35-46, doi: 10.3758/BRM.41.1.35 (2009).
31. Wise, L. A. et al. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study. Hum Reprod 19, 1746-1754, doi: 10.1093/humrep/deh309 (2004).
32. Inoue-Choi, M., Robien, K., Mariani, A., Cerhan, J. R. & Anderson, K. E. Sugar-sweetened beverage intake and the risk of type I and type II endometrial cancer among postmenopausal women. Cancer Epidemiol Biomarkers Pre 22, 2384-2394 (2013).
33. Prescott, J. et al. Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Pre 23, 1512-1520 (2014).
34. Gavrilyuk, O., Braaten, T., Skeie, G. & Lund, E. Coffee consumption and endometrial cancer risk among postmenopausal women in the norwegian women and cancer (NOWAC) study. Int J Gynecol Cancer 21, S509 (2011).
35. Giri, A., Reeves, K., Luisi, N., Balasubramanian, R. & Sturgeon, S. Coffee, tea consumption and endometrial cancer risk: A prospective cohort study. Am J Epidemiol 173, S233 (2011).
36. Uccella, S. et al. Coffee consumption and the risk of endometrial cancer in postmenopausal women. Gynecol Oncol 116, S75-S76 (2010).
37. Weiderpass, E. et al. Endometrial cancer in relation to coffee, tea, and caffeine consumption: a prospective cohort study among middle-aged women in sweden. Nut Cancer 66, 1132-1143, doi: 10.1080/01635581.2014.948214 (2014).
38. Uccella, S. et al. Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer. Brit J Cancer 109, 1908-1913, doi: 10.1038/bjc.2013.540 (2013).
39. Stensvold, I. & Jacobsen, B. K. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Cause Control 5, 401-408 (1994).
40. Shimazu, T. et al. Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 123, 2406-2410, doi: 10.1002/ijc.23760 (2008).
41. Nilsson, L. M., Johansson, I., Lenner, P., Lindahl, B. & Van Guelpen, B. Consumption of filtered and boiled coffee and the risk of incident cancer: A prospective cohort study. Cancer Cause Control 21, 1533-1544 (2010).
42. Je, Y., Hankinson, S. E., Tworoger, S. S., DeVivo, I. & Giovannucci, E. A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemiol Biomarkers Pre 20, 2487-2495 (2011).
43. Jacobsen, B. K., Bjelke, E., Kvale, G. & Heuch, I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76, 823-831 (1986).
44. Gunter, M. J. et al. A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer 131, E530-536, doi: 10.1002/ijc.26482 (2012).
45. Giri, A. et al. Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: a prospective cohort study among US postmenopausal women. Nutrients 3, 937-950, doi: 10.3390/nu3110937 (2011).
46. Gavrilyuk, O. et al. High coffee consumption and different brewing methods in relation to postmenopausal endometrial cancer risk in the Norwegian women and cancer study: a population-based prospective study. BMC Womens Health 14, 48, doi: 10.1186/1472-6874-14-48 (2014).
47. Friberg, E., Orsini, N., Mantzoros, C. S. & Wolk, A. Coffee drinking and risk of endometrial cancer - A population-based cohort study. Int J Cancer 125, 2413-2417 (2009).
48. Merritt, M. A. et al. Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and Nurses' Health Study (NHS) and NHSII. Cancer Epidemiol Biomarkers Pre 24, 466-471, doi: 10.1158/1055-9965. EPI-14-0970 (2015).
49. Wang, W., He, M. & Zhang, X. Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies. PloS one 9, e110667, doi: 10.1371/journal.pone.0110667 (2014).
50. Ferrini, R. L. & Barrett-Connor, E. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol 144, 642-644 (1996).
51. Garattini, S. Caffeine, coffee, and health. Vol. 5 (Raven Press New York, 1993).
52. Cavin, C. et al. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40, 1155-1163 (2002).
53. Loopstra-Masters, R. C., Liese, A. D., Haffner, S. M., Wagenknecht, L. E. & Hanley, A. J. Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia 54, 320-328, doi: 10.1007/s00125-010-1957-8 (2011).
54. Wu, T., Willett, W. C., Hankinson, S. E. & Giovannucci, E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 28, 1390-1396 (2005).
55. Oh, J. K. et al. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Int J Cancer, doi: 10.1002/ijc.29569 (2015).
56. Nilsson, L. M. et al. Consumption of filtered and boiled coffee and the risk of first acute myocardial infarction: a nested case/referent study. Nutr Metab Cardiovasc Dis 20, 527-535, doi: 10.1016/j.numecd.2009.05.004 (2010).
57. Setiawan, V. W. et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31, 2607-2618, doi: 10.1200/jco.2012.48.2596 (2013).
58. Dong, J. Y., Zhang, Y. H. & Qin, L. Q. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58, 1378-1385, doi: 10.1016/j.jacc.2011.06.024 (2011).
59. Hill, A. B. The environment and disease: association or causation? Proceedings of the Royal Society of Medicine 58, 295 (1965).